Buy Rcnet 12.5mg in UAE | Ernest Oncology – Oncology Meds Supplier

Rcnet 12.5mg Capsule: Advanced Sunitinib Therapy for Global Cancer Care

Are you looking for a trusted Rcnet 12.5 mg capsule exporter from India? Ernest Oncology, a premier division of Ernest Pharmaceutical Pvt. Ltd., is a leading international bulk supplier and distributor. We provide high-quality oncology solutions to the USA, UK (London), UAE (Abu Dhabi), Australia, and South Africa, ensuring streamlined logistics and professional B2B service.

Product Overview: What is Rcnet 12.5mg?

Rcnet 12.5 mg contains Sunitinib, a powerful multi-targeted receptor tyrosine kinase (RTK) inhibitor. It is designed to disrupt the signaling pathways that allow cancer cells to grow, divide, and form new blood vessels (angiogenesis). As a high-quality pharmaceutical export, Rcnet serves as a vital component in modern oncology treatment protocols worldwide.

Therapeutic Indications:

Rcnet 12.5mg is primarily prescribed for the management of:

• Metastatic Renal Cell Carcinoma (mRCC): An advanced form of kidney cancer.

• Gastrointestinal Stromal Tumor (GIST): For patients who are resistant to or cannot tolerate imatinib therapy.

• Pancreatic Neuroendocrine Tumors (pNET): Progressive, well-differentiated tumors of the pancreas.

• Adjuvant Treatment of RCC: Used post-surgery to reduce the risk of cancer recurrence in high-risk patients.

How Rcnet Works (Mechanism of Action):

Rcnet belongs to the class of Tyrosine Kinase Inhibitors (TKIs). It works by blocking several specific proteins (kinases) on the surface of cancer cells and the blood vessels that supply them.

1. Anti-Angiogenesis: It inhibits VEGFR (Vascular Endothelial Growth Factor Receptor), effectively "starving" the tumor by preventing the growth of new blood vessels.

2. Tumor Growth Inhibition: It targets PDGFR (Platelet-Derived Growth Factor Receptor) and c-KIT, which are critical for the survival and proliferation of cancer cells.

3. Targeted Precision: By focusing on these specific pathways, Rcnet helps to slow down or stop the spread of malignancy.

Dosage and Administration:

• Standard Regimen: For RCC and GIST, the typical cycle is 50 mg (multiple capsules) daily for 4 weeks, followed by a 2-week rest period.

• Continuous Protocol: For pancreatic neuroendocrine tumors, a lower continuous daily dose (often 37.5 mg) is standard.

• Method: Should be swallowed whole with water. It can be taken with or without food.

• Important Note: Avoid grapefruit and Seville oranges during treatment, as they can interfere with how the medication is processed by the body.

Common Side Effects

Patients using Rcnet 12.5mg should be monitored for:

• Fatigue and weakness.

• Hand-Foot Syndrome: Skin redness, swelling, or pain on the palms and soles.

• Hypertension (High Blood Pressure).

• Altered taste or skin/hair discoloration.

Why Choose Ernest Oncology for Recent 12.5 mg?

• Strategic Global Logistics: Direct shipping to the USA, UK, UAE, Australia, and South Africa.

• Authentic Indian Exports: We source from reputable manufacturers, ensuring product integrity and GMP compliance.

• Competitive B2B Pricing: Specialized pricing models for oncology clinics, hospitals, and pharmacies.

• Expert Documentation: We handle all international pharmaceutical export regulations and customs paperwork.